EULAR recommendations for a core data set for pregnancy registries in rheumatology.

Meissner, Yvette; Fischer-Betz, Rebecca; Andreoli, Laura; Costedoat-Chalumeau, Nathalie; De Cock, Diederik; Dolhain, Radboud J E M; Förger, Frauke; Goll, Doreen; Molto, Anna; Nelson-Piercy, Catherine; Özdemir, Rebecca; Raio, Luigi; Rodríguez-García, Sebastian Cruz; Sciascia, Savino; Wallenius, Marianne; Zbinden, Astrid; Zink, Angela; Strangfeld, Anja (2021). EULAR recommendations for a core data set for pregnancy registries in rheumatology. Annals of the rheumatic diseases, 80(1), pp. 49-56. BMJ Publishing Group 10.1136/annrheumdis-2020-218356

[img]
Preview
Text
EULAR_recommendations_for_a_core_F_rger_2020.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (793kB) | Preview

BACKGROUND AND OBJECTIVE

There is an urgent need for robust data on the trajectories and outcomes of pregnancies in women with inflammatory rheumatic diseases (IRD). In particular when rare outcomes or rare diseases are to be investigated, collaborative approaches are required. However, joint data analyses are often limited by the heterogeneity of the different data sources.To facilitate future research collaboration, a European League Against Rheumatism (EULAR) Task Force defined a core data set with a minimum of items to be collected by pregnancy registries in rheumatology covering the period of pregnancy and the 28-day neonatal phase in women with any underlying IRD.

METHODS

A stepwise process included a two-round Delphi survey and a face-to-face meeting to achieve consensus about relevant items.

RESULTS

A total of 64 multidisciplinary stakeholders from 14 different countries participated in the two rounds of the Delphi process. During the following face-to-face meeting of the EULAR Task Force, consensus was reached on 51 main items covering 'maternal information', 'pregnancy' and 'treatment'. Generic instruments for assessment are recommended for every item. Furthermore, for the five most frequent IRDs rheumatoid arthritis, spondyloarthritis, juvenile idiopathic arthritis, systemic lupus erythematosus and other connective tissue diseases, disease-specific laboratory markers and disease activity measurements are proposed.

CONCLUSION

This is the first consensus-based core data set for prospective pregnancy registries in rheumatology. Its purpose is to stimulate and facilitate multinational collaborations that aim to increase the knowledge about pregnancy course and safety of treatment in women with IRDs during pregnancy.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Förger, Frauke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-4967

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Marlise Bühler Zimmermann

Date Deposited:

27 Jan 2021 14:57

Last Modified:

17 Mar 2021 04:08

Publisher DOI:

10.1136/annrheumdis-2020-218356

PubMed ID:

33055080

Uncontrolled Keywords:

antirheumatic agents autoimmune diseases biological therapy epidemiology health care outcome assessment

BORIS DOI:

10.48350/149386

URI:

https://boris.unibe.ch/id/eprint/149386

Actions (login required)

Edit item Edit item
Provide Feedback